Utilizing α-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma

Annals of Surgery

Volumn 240, Issue 4, 2004, Pages 659-666

  Pin, Richard H ^a   Reinblatt, Maura ^a,b   Fong, Yuman ^a   Raper, Steven E ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; LUCIFERASE; RIBONUCLEOTIDE REDUCTASE;

ANTIGEN EXPRESSION; CANCER INHIBITION; CONFERENCE PAPER; CYTOTOXICITY; ENHANCER REGION; ENZYME SYNTHESIS; HEPATOMA CELL; HERPES VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; ALPHA-FETOPROTEINS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GENES, VIRAL; GENETIC VECTORS; HUMANS; LUCIFERASES; MALE; MICE; MICE, NUDE; MUTATION; NEOPLASM TRANSPLANTATION; PROMOTER REGIONS (GENETICS); RIBONUCLEOTIDE REDUCTASES; SIMPLEXVIRUS; TRANSFECTION; VIRUS REPLICATION;

EID: 4644237409     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000141197.57930.7a     Document Type: Conference Paper

References (17)

1. Nakabayashi H, Hashimoto T, Miyao Y, et al. A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma. Mol Cell Biol. 1991;11:5885-5893.
2. Cao G, Kuriyama S, Tsujinoue H, et al. A novel approach for inducing enhanced and selective transgene expression in hepatocellular-carcinoma cells. Int J Cancer. 2000;87:247-252.
3. He P, Tang ZY, Liu BB, et al. The targeted expression of the human interleukin-2/interferon alpha2b fused gene in alpha-fetoprotein-expressing hepatocellular carcinoma cells. J Cancer Res Clin Oncol. 1999;125:77-82.
4. Chen H, Egan JO, Chiu JF. Regulation and activities of alpha-fetoprotein. Crit Rev Eukaryot Gene Expr. 1997;7:11-41.
5. Kajiyama Y, Tian J, Locker J. Regulation of alpha-fetoprotein expression by Nkx2.8. Mol Cell Biol. 2002;22:6122-6130.
6. Watanabe K, Saito A, Tamaoki T. Cell-specific enhancer activity in a far upstream region of the human alpha-fetoprotein gene. J Biol Chem. 1987;262:4812-4818.
7. Mineta T, Rabkin SD, Yazaki T, et al. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat Med. 1995;1:938-943.
8. Mineta T, Rabkin SD, Martuza RL. Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. Cancer Res. 1994;54:3963-3966.
9. Belayew A, Tilghman SM. Genetic analysis of alpha-fetoprotein synthesis in mice. Mol Cell Biol. 1982;2:1427-1435.
10. Kanai F, Shiratori Y, Yoshida Y, et al. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Hepatology. 1996;23:1359-1368.
11. Kanai F, Lan KH, Shiratori Y, et al. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. Cancer Res. 1997;57:461-465.
12. Ido A, Nakata K, Kato Y, et al. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter. Cancer Res. 1995;55:3105-3109.
13. Alexander F, Young PR, Tilghman SM. Evolution of the albumin: alpha-fetoprotein ancestral gene from the amplification of a 27 nucleotide sequence. J Mol Biol. 1984;173:159-173.
14. Levan G, Szpirer J, Szpirer C, et al. The gene map of the Norway rat (Rattus norvegicus) and comparative mapping with mouse and man. Genomics. 1991;10:699-718.
15. Urano Y, Sakai M, Watanabe K, et al. Tandem arrangement of the albumin and alpha-fetoprotein genes in the human genome. Gene. 1984;32:255-261.
16. Vacher J, Camper SA, Krumlauf R, et al. Raf regulates the postnatal repression of the mouse alpha-fetoprotein gene at the posttranscriptional level. Mol Cell Biol. 1992;12:856-864.
17. Su H, Lu R, Chang JC, et al. Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice. Proc Natl Acad Sci U S A. 1997;94:13891-13896.